Cargando…
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis
BACKGROUND: Critical illness is characterized by a loss of commensal flora and an overgrowth of potentially pathogenic bacteria, leading to a high susceptibility to nosocomial infections. Probiotics are living non-pathogenic microorganisms, which may protect the gut barrier, attenuate pathogen overg...
Autores principales: | Manzanares, William, Lemieux, Margot, Langlois, Pascal L., Wischmeyer, Paul E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991010/ https://www.ncbi.nlm.nih.gov/pubmed/27538711 http://dx.doi.org/10.1186/s13054-016-1434-y |
Ejemplares similares
-
Erratum to: Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis
por: Manzanares, William, et al.
Publicado: (2017) -
Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis
por: Manzanares, William, et al.
Publicado: (2015) -
High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis
por: Manzanares, William, et al.
Publicado: (2016) -
Response to “Reassessing the death risk related to probiotics in critically ill patients”
por: Manzanares, William, et al.
Publicado: (2017) -
Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness
por: Wischmeyer, Paul E., et al.
Publicado: (2016)